An interventional study of Structured Dementia Management Competency Training Program and Self-directed Dementia Learning in Dementia and Primary Health Care Providers, sponsored by Fujian Medical University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-03.
Sponsored by Fujian Medical University · Not applicable, Interventional, and Other
This study aims to evaluate the effectiveness and implementation outcomes of a dementia management competency training program for primary healthcare workers. A cluster randomized controlled trial will be conducted among primary healthcare institutions in Nanping, Fujian Province, China. Eligible primary health care providers will be recruited from community health service centers and township health centers.Participating institutions will be randomized in a 1:1 ratio to either a structured dementia management training group or a self-directed learning control group. The intervention group will receive a 12-week blended training program, including online learning, an in-person skills workshop, and case-based practice supervision. The control group will receive self-directed online learning materials. Outcomes will be assessed at baseline, immediately after the intervention, and 3 months after the intervention. The primary outcome is the change in dementia knowledge, measured using the Dementia Knowledge Assessment Scale. Secondary outcomes include dementia-related attitudes, dementia management practice competency, self-reported dementia management behaviors, objective screening and referral-related indicators, and implementation outcomes based on the RE-AIM framework.
This study uses a hybrid effectiveness-implementation design integrating a cluster randomized controlled trial and implementation evaluation. The trial will assess the effectiveness of a dementia management competency training program for primary health care providers at both the individual and organizational levels. At the individual level, the study will evaluate the effects of the training on dementia knowledge, attitudes, practice competency, and dementia management-related clinical behaviors. At the organizational level, the study will examine reach, adoption, implementation quality, and maintenance of the training program in real-world primary healthcare settings.The study will be conducted in community health service centers and township health centers in Nanping, Fujian Province, China. Primary healthcare institutions will serve as clusters. Approximately 16 institutions will be recruited and randomized to the intervention or control group at a 1:1 ratio, with approximately 20 primary health care providers recruited from each institution.The intervention group will receive a 12-week structured blended training program named "Hand in Hand Along the Memory Path". During weeks 1-4, participants will complete seven online learning modules, with a total learning duration of approximately 3 hours. At the end of week 4, participants will attend an in-person skills workshop of approximately 2 hours, focusing on standardized use of cognitive screening and assessment tools. During weeks 5-12, participants will take part in online case-based supervision every two weeks and complete practice tasks related to cognitive screening and dementia management.The control group will receive self-directed online learning materials, including the same knowledge module videos and text-based materials. However, the control group will not receive structured learning tasks, case analysis, knowledge tests, demonstration videos, forum-based support, learning reminders, expert support, toolkits, in-person workshops, or case-based supervision.Quantitative data will be collected at baseline, immediately after the intervention, and 3 months after the intervention. Semi-structured interviews will be conducted 3 months after the intervention to explore participants' experiences, implementation barriers and facilitators, and factors affecting maintenance. Quantitative and qualitative findings will be integrated according to the RE-AIM framework.
2,372 studies on the registry are indexed under Dementia; 574 are open to participants now.
This study's planned enrollment of 240 is above the median of 90 across 1,758 interventional studies indexed under Dementia.
Browse Dementia studies →Fujian Medical University is the lead sponsor of 148 studies on the registry; 52 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Primary healthcare workers aged 18 years or older
Registered healthcare professionals holding a formal license issued by the national health authority
At least 1 year of work experience
Able to access the internet using a computer, tablet, or mobile phone
Currently working in a participating community health service center or township health center
Willing to participate in the study and provide written
Exclusion Criteria:
Personnel who do not directly participate in patient disease management, including logistics or auxiliary staff
Interns, trainees, or students
Individuals currently participating in other similar dementia training interventions
Individuals planning to leave their current institution within the next 12 months
Individuals who refuse to participate in the study or decline to provide written
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group will receive a 12-week structured blended dementia management competency training program. The program includes online learning modules, an in-person skills workshop, case-based supervision, and practice tasks designed to improve dementia knowledge, attitudes, practice competency, and dementia management-related behaviors among primary health care providers.
Genetic: Structured Dementia Management Competency Training Program
Participants in this group will receive self-directed online learning materials related to dementia management. The materials include knowledge module videos and text-based resources but do not include structured learning tasks, case analysis, knowledge tests, demonstration videos, forum-based support, learning reminders, expert support, toolkits, in-person workshops, or case-based supervision.
Behavioral: Self-directed Dementia Learning
The intervention is a 12-week blended training program. During weeks 1-4, participants will complete seven online modules with a total learning duration of approximately 3 hours. At the end of week 4, participants will attend a 2-hour in-person skills workshop focusing on standardized cognitive screening and assessment. During weeks 5-12, participants will participate in online case-based supervision every two weeks and complete practice tasks, including cognitive screening records and dementia management case records.
Also known as: "Hand in Hand on the Memory Journey" dementia management training programme
Participants will be provided with online dementia-related learning materials and will arrange their own learning time and place. No structured completion requirements, assessments, in-person activities, or expert supervision will be provided.
Change in dementia knowledge score
Dementia knowledge will be measured using the Dementia Knowledge Assessment Scale. The primary outcome is the change in total DKAS score from baseline to immediately after the 12-week intervention. Higher scores indicate greater dementia knowledge.
Time frame: Baseline, immediately after the intervention, and 3 months after the intervention
Change in dementia-related attitudes and confidence
Dementia-related attitudes and confidence will be measured using the General Practitioners' Attitudes and Confidence Scale for Dementia. Higher scores indicate more positive attitudes and greater confidence.
Time frame: Baseline, immediately after the intervention, and 3 months after the intervention
Change in dementia management practice competency
Dementia management practice competency was measured using the Dementia Management Practice Competency Scale for Primary Care, which was developed by the research team. Higher scores on the scale indicate greater dementia management practice competency.
Time frame: Baseline, immediately after the intervention, and 3 months after the intervention
Change in self-reported dementia management-related behaviors
Participants will report the frequency of dementia management-related behaviors during the past month, including cognitive screening, identification of suspected cognitive impairment, referral recommendation, communication with patients or family members, and dementia-related health education.
Time frame: Baseline, immediately after the intervention, and 3 months after the intervention
Cognitive screening implementation rate
The cognitive screening implementation rate will be calculated as the number of patients aged 65 years or older who received cognitive screening divided by the total number of patients aged 65 years or older seen during the same period, multiplied by 100%.
Time frame: Baseline, immediately after the intervention, and 3 months after the intervention
Referral recommendation documentation rate
The referral recommendation documentation rate will be calculated as the number of screen-positive patients with documented referral recommendations divided by the total number of screen-positive patients, multiplied by 100%.
Time frame: Baseline, immediately after the intervention, and 3 months after the intervention
Online course completion rate
The proportion of intervention group participants who complete all online learning modules.
Time frame: Immediately after the intervention
In-person workshop attendance rate
The proportion of intervention group participants who attend the in-person skills workshop.
Time frame: Immediately after the intervention
Practice task completion rate
The proportion of intervention group participants who submit the required screening records and case management records.
Time frame: Immediately after the intervention
Online supervision participation rate
The number of online supervision sessions attended divided by the number of scheduled supervision sessions.
Time frame: Immediately after the intervention
Training satisfaction and acceptability
Satisfaction and acceptability will be assessed using a self-designed questionnaire with Likert-scale items and open-ended questions.
Time frame: Immediately after the intervention
Institutional maintenance of dementia-related practices
Institutional maintenance will be assessed using a questionnaire completed by institutional managers, including whether cognitive screening, result explanation, referral recommendation, or related training continues after the intervention.
Time frame: 3 months after the intervention
Barriers and facilitators to implementation and maintenance
Semi-structured interviews will be conducted with intervention group participants and institutional managers to explore implementation experiences, barriers, facilitators, and suggestions for optimization.
Time frame: 3 months after the intervention
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jun 2026; primary completion for Sep 2026, 3 months later.
Of 855 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 3 months is below that.
Counting every sponsor, half of 901 studies reached it within 25 months; a quarter within 11 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.